SeaChange Pharmaceuticals Company

SeaChange develops chemoinformatic and statistical methods to uncover links between drug molecules and the biological targets responsible for disease. SeaChange uses unique computational techniques to find new uses for drugs that are already safe. They aim to make better use of existing drugs, to reduce the likelihood of drug failure in clinical studies, and to reduce the need for toxicity testing in animals. Their technology is now available to the scientific community as the SEAwareв„ў prediction package. They find new uses for known drugs that are safe in humans, and advance the drugs to proof-of-concept. They also partner with pharma research groups to identify off-target effects underlying drug toxicity.
Technology: Community adn Social
Industry: P4 Medicine
Headquarters: United States
Founded Date: 2009
Employees Number: 1-10
Funding Status: undisclosed

Visit Website
Register and Claim Ownership